{{Rsnum
|rsid=2289681
|Gene=GFAP
|Chromosome=17
|position=44911720
|Orientation=plus
|GMAF=0.1423
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=GFAP
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 66.4 | 31.9 | 1.8
| HCB | 80.9 | 18.4 | 0.7
| JPT | 77.9 | 21.2 | 0.9
| YRI | 50.7 | 44.5 | 4.8
| ASW | 43.9 | 45.6 | 10.5
| CHB | 80.9 | 18.4 | 0.7
| CHD | 75.0 | 24.1 | 0.9
| GIH | 82.2 | 16.8 | 1.0
| LWK | 68.2 | 28.2 | 3.6
| MEX | 77.6 | 19.0 | 3.4
| MKK | 61.5 | 34.0 | 4.5
| TSI | 89.2 | 9.8 | 1.0
| HapMapRevision=28
}}Mentioned in a [https://www.23andme.com/you/community/thread/3574/ 23andMe discussion] on [[intelligence]].

Synonymous Polymorphisms at Splicing Regulatory Sites are Associated with CpGs in Neurodegenerative Disease-Related Genes.{{PMID|20077034}}

{{ClinVar
|rsid=2289681
|Reversed=0
|FwdREF=C
|FwdALT=T
|REF=C
|ALT=T
|RSPOS=42989088
|CHROM=17
|GMAF=0.1419
|dbSNPBuildID=100
|SSR=0
|SAO=0
|VP=0x050160000000170517100101
|GENEINFO=GFAP:2670
|GENE_NAME=GFAP
|GENE_ID=2670
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000017.10:g.42989088C>T
|CLNSIG=1
|Tags=PM;SLO;VLD;G5A;G5;HD;GNO;KGPhase1;KGPROD;OTHERKG;PH3;LSD
|CAF=0.8577; 0.1423
|COMMON=1
|CLNACC=RCV000056912.1
|CLNDBN=not provided
|CLNSRC=Epithelial Biology
|CLNSRCID=GFAP:c.858G>A
|Disease=not provided
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}